Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine in Children and Adolescents With Bipolar Spectrum Disorder
NCT02357290Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2014
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetylcysteine in bipolar disorder (BD), sponsored by Massachusetts General Hospital. Started Jan 2014; status: completed.
02
Drugs
acetylcysteine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02357290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02357290.